BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Syed YY. Recombinant Zoster Vaccine (Shingrix®): A Review in Herpes Zoster. Drugs Aging 2018;35:1031-40. [DOI: 10.1007/s40266-018-0603-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Chen P, Shi X, He W, Zhong G, Tang Y, Wang H, Zhang P. mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic. Hum Vaccin Immunother 2022;18:2040330. [PMID: 35321627 DOI: 10.1080/21645515.2022.2040330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 He Y, Zhang W, Xiao Q, Fan L, Huang D, Chen W, He W. Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment. Asian J Pharm Sci 2022;17:817-37. [PMID: 36415834 DOI: 10.1016/j.ajps.2022.11.002] [Reference Citation Analysis]
3 Scalabrin S, Becco A, Vitale A, Nuzzi R. Ocular effects caused by viral infections and corresponding vaccines: An overview of varicella zoster virus, measles virus, influenza viruses, hepatitis B viruses, and SARS-CoV-2. Front Med 2022;9. [DOI: 10.3389/fmed.2022.999251] [Reference Citation Analysis]
4 Goharshadi EK, Goharshadi K, Moghayedi M. The use of nanotechnology in the fight against viruses: A critical review. Coordination Chemistry Reviews 2022;464:214559. [DOI: 10.1016/j.ccr.2022.214559] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shan P, Wang Z, Li J, Wei D, Zhang Z, Hao S, Hou Y, Wang Y, Li S, Wang X, Xu J. A New Nano Adjuvant of PF3 Used for an Enhanced Hepatitis B Vaccine. Front Bioeng Biotechnol 2022;10:903424. [PMID: 35620473 DOI: 10.3389/fbioe.2022.903424] [Reference Citation Analysis]
6 Selma OC, Yáñez DC, Sánchez FG, Gómez AS. Infecciones por el virus del grupo herpes. Medicine - Programa de Formación Médica Continuada Acreditado 2022;13:3353-3360. [DOI: 10.1016/j.med.2022.05.022] [Reference Citation Analysis]
7 Guillo L, Rabaud C, Choy EH, D'Amico F, Danese S, Ng SC, Peyrin-Biroulet L. Herpes Zoster and Vaccination Strategies in Inflammatory Bowel Diseases: A Practical Guide. Clin Gastroenterol Hepatol 2022;20:481-90. [PMID: 33080353 DOI: 10.1016/j.cgh.2020.10.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
8 Tretiakova DS, Vodovozova EL. Liposomes as Adjuvants and Vaccine Delivery Systems. Biochem (Mosc) Suppl Ser A Membr Cell Biol 2022;16:1-20. [PMID: 35194485 DOI: 10.1134/S1990747822020076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Yang J, Tseng J, Yu G, Luo Y, Huang CF, Hong Y, Chuang T. Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. Pharmaceutics 2022;14:423. [DOI: 10.3390/pharmaceutics14020423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Carmans L, Van Dessel C. Herpes zoster-encefalitis: een diagnostische uitdaging bij de geriatrische patiënt. Tijdschr Geneesk 2022. [DOI: 10.47671/tvg.77.21.190] [Reference Citation Analysis]
11 Zingaropoli MA, Pasculli P, Iannetta M, Perri V, Tartaglia M, Crisafulli SG, Merluzzo C, Baione V, Mazzochi L, Taglietti A, Pauri F, Frontoni M, Altieri M, Gaeta A, Antonelli G, Conte A, Mastroianni CM, Ciardi MR. Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study. Mult Scler J Exp Transl Clin 2022;8:20552173211065731. [PMID: 35003758 DOI: 10.1177/20552173211065731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Meppen M, Stranges D. QbD approach to formulation development for protein-based vaccines. Practical Aspects of Vaccine Development 2022. [DOI: 10.1016/b978-0-12-814357-5.00004-0] [Reference Citation Analysis]
13 Calvet X, Carpio D, Rodríguez-lago I, García-vicuña R, Barreiro-de-acosta M, Juanola X, Aguas M, Castillo C, Gratacós J. Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies. Gastroenterología y Hepatología (English Edition) 2021;44:587-598. [DOI: 10.1016/j.gastre.2021.01.003] [Reference Citation Analysis]
14 Lai SW, Liao KF, Lin CL, Kuo YH, Liu CS, Hwang BF. The incidence rate of herpes zoster in inflammatory bowel disease: A meta-analysis of cohort studies. Medicine (Baltimore) 2021;100:e26863. [PMID: 34414937 DOI: 10.1097/MD.0000000000026863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Lu X, Lu J, Zhang F, Wagner AL, Zhang L, Mei K, Guan B, Lu Y. Low willingness to vaccinate against herpes zoster in a Chinese metropolis. Hum Vaccin Immunother 2021;:1-8. [PMID: 34370590 DOI: 10.1080/21645515.2021.1960137] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang Q, Liu Z. Recent progress of surface plasmon resonance in the development of coronavirus disease-2019 drug candidates. Eur J Med Chem Rep 2021;1:100003. [PMID: 36304139 DOI: 10.1016/j.ejmcr.2021.100003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Chon BH, Hwang CJ, Perry JD. Unilateral Ptosis, Proptosis, and Orbital Myositis After Shingles Vaccination. Ophthalmic Plast Reconstr Surg 2021;37:e100-3. [PMID: 33079763 DOI: 10.1097/IOP.0000000000001847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
18 Sibanda M, Meyer JC, Mahlaba KJ, Burnett RJ. Promoting Healthy Ageing in South Africa Through Vaccination of the Elderly. Front Public Health 2021;9:635266. [PMID: 33981664 DOI: 10.3389/fpubh.2021.635266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Schijns V, Majhen D, van der Ley P, Thakur A, Summerfield A, Berisio R, Nativi C, Fernández-Tejada A, Alvarez-Dominguez C, Gizurarson S, Zamyatina A, Molinaro A, Rosano C, Jakopin Ž, Gursel I, McClean S. Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation. Pharmaceutics 2021;13:501. [PMID: 33917629 DOI: 10.3390/pharmaceutics13040501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Lang PO, Aspinall R. Vaccination for quality of life: herpes-zoster vaccines. Aging Clin Exp Res 2021;33:1113-22. [PMID: 31643072 DOI: 10.1007/s40520-019-01374-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Calvet X, Carpio D, Rodríguez-Lago I, García-Vicuña R, Barreiro-de-Acosta M, Juanola X, Aguas M, Castillo C, Gratacós J. Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies. Gastroenterol Hepatol 2021:S0210-5705(21)00056-X. [PMID: 33640469 DOI: 10.1016/j.gastrohep.2021.01.007] [Reference Citation Analysis]
22 Sorel O, Messaoudi I. Insights into the pathogenesis of varicella viruses. Curr Clin Microbiol Rep 2019;6:156-65. [PMID: 32999816 DOI: 10.1007/s40588-019-00119-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Witkowski JM, Bryl E, Fulop T. Should we Try to Alleviate Immunosenescence and Inflammaging - Why, How and to What Extent? Curr Pharm Des 2019;25:4154-62. [PMID: 31713479 DOI: 10.2174/1381612825666191111153016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
24 Singh G, Song S, Choi E, Lee PB, Nahm FS. Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia. Korean J Pain 2020;33:201-7. [PMID: 32606264 DOI: 10.3344/kjp.2020.33.3.201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Dai L, Zheng T, Xu K, Han Y, Xu L, Huang E, An Y, Cheng Y, Li S, Liu M, Yang M, Li Y, Cheng H, Yuan Y, Zhang W, Ke C, Wong G, Qi J, Qin C, Yan J, Gao GF. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS. Cell 2020;182:722-733.e11. [PMID: 32645327 DOI: 10.1016/j.cell.2020.06.035] [Cited by in Crossref: 271] [Cited by in F6Publishing: 195] [Article Influence: 90.3] [Reference Citation Analysis]
26 Wang ZB, Xu J. Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant-Antigen Codelivery. Vaccines (Basel) 2020;8:E128. [PMID: 32183209 DOI: 10.3390/vaccines8010128] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 17.3] [Reference Citation Analysis]
27 Miller SM, Cybulski V, Whitacre M, Bess LS, Livesay MT, Walsh L, Burkhart D, Bazin HG, Evans JT. Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in Mice. Front Immunol 2020;11:406. [PMID: 32210973 DOI: 10.3389/fimmu.2020.00406] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
28 Russell HG, Tankersley MS. Recombinant zoster vaccine administration in an allergy and immunology practice: A medical and economic case. Ann Allergy Asthma Immunol 2020;124:517-8. [PMID: 32088321 DOI: 10.1016/j.anai.2020.02.006] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Saadatian-Elahi M, Bauduceau B, Del-Signore C, Vanhems P. Diabetes as a risk factor for herpes zoster in adults: A synthetic literature review. Diabetes Res Clin Pract 2020;159:107983. [PMID: 31846665 DOI: 10.1016/j.diabres.2019.107983] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
30 Coll PP, Costello VW, Kuchel GA, Bartley J, McElhaney JE. The Prevention of Infections in Older Adults: Vaccination. J Am Geriatr Soc 2020;68:207-14. [PMID: 31613000 DOI: 10.1111/jgs.16205] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
31 Ryndak MB, Laal S. Mycobacterium tuberculosis Primary Infection and Dissemination: A Critical Role for Alveolar Epithelial Cells. Front Cell Infect Microbiol 2019;9:299. [PMID: 31497538 DOI: 10.3389/fcimb.2019.00299] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
32 Wang N, Chen M, Wang T. Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization. J Control Release 2019;303:130-50. [PMID: 31022431 DOI: 10.1016/j.jconrel.2019.04.025] [Cited by in Crossref: 98] [Cited by in F6Publishing: 105] [Article Influence: 24.5] [Reference Citation Analysis]
33 Ecarnot F, Maggi S, Michel J. Vaccination (Prophylaxis) in the Elderly. Reference Module in Biomedical Sciences 2019. [DOI: 10.1016/b978-0-12-801238-3.11390-x] [Reference Citation Analysis]
34 Sorel O, Messaoudi I. Varicella Virus-Host Interactions During Latency and Reactivation: Lessons From Simian Varicella Virus. Front Microbiol 2018;9:3170. [PMID: 30619226 DOI: 10.3389/fmicb.2018.03170] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]